<DOC>
	<DOCNO>NCT00780117</DOCNO>
	<brief_summary>Contribute support hypothesis relationship gene involve oncogenesis involve embryological development .</brief_summary>
	<brief_title>Characterization At-risk Population Pre-sacral Tumor CURRARINO Syndrome</brief_title>
	<detailed_description>CURRARINO syndrome ( CS ) ( OMIM 176450 ) rare congenital disease describe 1981 , association , least , three main clinical feature : typical sacral malformation ( sickled-shape sacrum total sacral agenesis S2 ) , hindgut anomaly pre-sacral tumor . To date , neurological defect , tether cord and/or lipoma filum conus , light fourth major clinical sign.In half case , CS ascribe heterozygous mutation HLXB9 gene ( MNX1 gene , OMIM 142994 ) locate 7q36 , autosomal dominant mode inheritance . The HLXB9 gene involved motoneuron caudal development embryo . However , genetic heterogeneity suspect , since patient without HLXB9 mutation harbour subtle phenotypic variation . Presently , locus identify . The pre-sacral tumor develop almost 80 % CS . When teratoma ( 30 % case ) , may turn malignancy 1 4 % case , accord literature . As far know , clinical , molecular pathological marker operational predict tumoral evolution give prognosis . Major aim study find correlation clinical sign , constitutional somatic genetic anomaly HLXB9 gene candidate gene , and/or pathological feature tumoral evolution CS . Evaluation pre-sacral tumor evolution base local recurrence distance metastasis surgical removal . Annual serum alpha-foeto-protein level monitoring also perform , unique marker teratoma.This study specifically require annual clinical examination lumbar-sacral MRI imaging , three blood sample inclusion annual blood sample.This multicentric study last least 6 year . Eighty patient include follow least 3 year . Finally , study may help identify group at-risk patient tumor development malignant transformation pre-sacral teratoma . It also help define objective clinical , radiological , molecular , pathological and/or biological criterion long last survey . In general , may also contribute support hypothesis close relationship gene involve oncogenesis involve embryological development .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Teratoma</mesh_term>
	<mesh_term>Digestive System Abnormalities</mesh_term>
	<mesh_term>Syringomyelia</mesh_term>
	<criteria>At least 1 4 major sign CURRARINO syndrome : 1 . Sacral agenesis 2 . Hindgut malformation chronic constipation 3 . Presacral tumor and/or 4 . TETHECORD syndrome and/or lipoma filum conus Anomaly genotyping HLXB9 without clinical expression Opposition sign inform consent agreement</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>CURRARINO syndrome</keyword>
	<keyword>Sacrococcygeal teratoma</keyword>
	<keyword>HLXB9 ( MNX1 ) gene</keyword>
	<keyword>Alpha foeto protein</keyword>
	<keyword>Prognosis factor</keyword>
</DOC>